Rudi Pauwels

About

Rudi Pauwels, CEO of Biocartis, founded the company in 2007. He also (co)founded several other biotech companies, including Tibotec, Virco and Galapagos Genomics. He also serves as Executive Chairman. Rudi is a pharmacist who started as a researcher at the Rega Institute for Medical Research in Leuven, Belgium, an academic research center that is internationally renowned for its pioneering work in the field of antiviral chemotherapy. For more than two decades Rudi has focused on the search and development of anti-HIV drugs – a number of which have been approved and introduced on the market – and the development of diagnostic tools to allow personalized HIV treatment. Both his research and entrepreneurial career are driven by the needs of patients and a passion for advancing and medicine and leaving his mark. Rudi is (co-)author of more than 150 papers in peer-reviewed journals and is the recipient of several awards for his scientific and entrepreneurial accomplishments. Rudi has a

Investment Focus

Location

Mechelen, Belgium